Mana Namiki

Smad1 and Smad5 Act Downstream of Intracellular Signalings of BMP-2 That Inhibits Myogenic Differentiation and Induces Osteoblast Differentiation in C2C12 Myoblasts

Naoya Yamamoto, Shuichi Akiyama, Takenobu Katagiri et al. · Biochemical and Biophysical Research Communications · 1997 · 221 citations

Bmp-2 That, Sclerostin, Molecular Physiology +9

Bone Morphogenetic Protein-2 Inhibits Terminal Differentiation of Myogenic Cells by Suppressing the Transcriptional Activity of MyoD and Myogenin

Takenobu Katagiri, Shuichi Akiyama, Mana Namiki et al. · Experimental Cell Research · 1997 · 138 citations

Regenerative Medicine, Transcriptional Regulation, Sclerostin +8

Constitutively Active BMP Type I Receptors Transduce BMP-2 Signals without the Ligand in C2C12 Myoblasts

Shuichi Akiyama, Takenobu Katagiri, Mana Namiki et al. · Experimental Cell Research · 1997 · 105 citations

Molecular Physiology, Signal Transduction, Active Bmp Type +9

A Kinase Domain-truncated Type I Receptor Blocks Bone Morphogenetic Protein-2-induced Signal Transduction in C2C12 Myoblasts

Mana Namiki, Shuichi Akiyama, Takenobu Katagiri et al. · Journal of Biological Chemistry · 1997 · 83 citations · Full text

Regenerative Medicine, Mechanobiology, Sclerostin +15

Bone Morphogenetic Protein-12 and -13 Inhibit Terminal Differentiation of Myoblasts, but Do Not Induce Their Differentiation into Osteoblasts

Masaki Inada, Takenobu Katagiri, Shuichi Akiyama et al. · Biochemical and Biophysical Research Communications · 1996 · 63 citations

Mechanobiology, Sclerostin, Developmental Biology +8